Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trialHarold Atkins, Mark S. Freedman, Dean Fergusson et al.|The Lancet|2016Cited by 327
Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell TransplantationAdam Bryant, Christopher Bredeson, Harold Atkins et al.|JAMA Neurology|2016Cited by 103
A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantationIsabelle Bence‐Bruckler, Lothar Huebsch, Christopher Bredeson et al.|Bone Marrow Transplantation|1998Cited by 48
Autologous Stem Cell Transplantation for Stiff Person SyndromeSheilagh Sanders, Harold Atkins, Christopher Bredeson et al.|JAMA Neurology|2014Cited by 46
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignanciesNatasha Kekre, Brad H. Nelson, Kevin A. Hay et al.|Frontiers in Immunology|2022Cited by 31